Evidence map›Paper›PMID 24958871›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells.

Shereen Jamaladdin, Richard D W Kelly, Laura O'Regan, Oliver M Dovey, Grace E Hodson, Christopher J Millard, Nicola Portolano, Andrew M Fry, John W R Schwabe, Shaun M Cowley

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Zscan4 mediates ubiquitination and degradation of the corepressor complex to promote chromatin accessibility in 2C-like cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shereen JamaladdinDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Richard D W KellyDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Laura O'ReganDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Oliver M DoveyWellcome Trust Sanger Institute, Hinxton, Cambs CB10 1SA, United Kingdom.
Grace E HodsonDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Christopher J MillardDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Nicola PortolanoDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Andrew M FryDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
John W R SchwabeDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and.
Shaun M CowleyDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; and smc57@le.ac.uk.
University of Leicester · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J009598/1Medical Research Council G0600135Medical Research Council MR/J009202/1Wellcome Trust 085408Wellcome Trust 100237Wellcome Trust 100237/Z/12/Z
6 · The paper itself

Abstract

Histone deacetylases 1 and 2 (HDAC1/2) form the core catalytic components of corepressor complexes that modulate gene expression. In most cell types, deletion of both Hdac1 and Hdac2 is required to generate a discernible phenotype, suggesting their activity is largely redundant. We have therefore generated an ES cell line in which Hdac1 and Hdac2 can be inactivated simultaneously. Loss of HDAC1/2 resulted in a 60% reduction in total HDAC activity and a loss of cell viability. Cell death is dependent upon cell cycle progression, because differentiated, nonproliferating cells retain their viability. Furthermore, we observe increased mitotic defects, chromatin bridges, and micronuclei, suggesting HDAC1/2 are necessary for accurate chromosome segregation. Consistent with a critical role in the regulation of gene expression, microarray analysis of Hdac1/2-deleted cells reveals 1,708 differentially expressed genes. Significantly for the maintenance of stem cell self-renewal, we detected a reduction in the expression of the pluripotent transcription factors, Oct4, Nanog, Esrrb, and Rex1. HDAC1/2 activity is regulated through binding of an inositol tetraphosphate molecule (IP4) sandwiched between the HDAC and its cognate corepressor. This raises the important question of whether IP4 regulates the activity of the complex in cells. By rescuing the viability of double-knockout cells, we demonstrate for the first time (to our knowledge) that mutations that abolish IP4 binding reduce the activity of HDAC1/2 in vivo. Our data indicate that HDAC1/2 have essential and pleiotropic roles in cellular proliferation and regulate stem cell self-renewal by maintaining expression of key pluripotent transcription factors.

Indexed as

AcetylationAnimalsCell DivisionEmbryonic Stem CellsGene Expression RegulationHistone Deacetylase 1Histone Deacetylase 2HistonesMiceMice, KnockoutPluripotent Stem CellsTranscription FactorsHdac1 protein, mouseHdac2 protein, mouseHistone Deacetylase 1Histone Deacetylase 2HistonesTranscription Factors

Identifiers

PMID24958871
PMCPMC4103379
OpenAlexW2136121675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.